Bristol-Myers Squibb Company (BMY) New York Stock Exchange
46.85-0.27-0.57%
CloseMay 17, 2019

News: updated – 20-May 04:12


Cel-Sci’s Phase 3 Multikine Trial Has ‘Not Yet Hit The Primary Endpoint’18-May 04:21(SeekingAlpha)

May 8, 2019, saw Cel-Sci Corporation ( CVM ) releasing this statement: "The first four months of this year have already been very positive for us. Our Phase 3 head and neck cancer study is continuing and we are moving forward… We believe the following developments with regard to the M…

Tracking Seth Klarman’s Baupost Group Holdings – Q1 2019 Update18-May 03:28(SeekingAlpha)

This article is part of a series that provide an ongoing analysis of the changes made to Baupost Group’s 13F stock portfolio on a quarterly basis. It is based on Klarman’s regulatory 13F Form filed on 05/15/2019. Please visit our Tracking Seth Klarman’s Baupost Group Holdings article for a…